- Home
- LOMA vs BLDEW Comparison
LOMA vs BLDEW Comparison
Compare LOMA & BLDEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOMA
- BLDEW
- Stock Information
- Founded
- LOMA 1926
- BLDEW 2014
- Country
- LOMA Argentina
- BLDEW United States
- Employees
- LOMA N/A
- BLDEW 281
- Industry
- LOMA Building Materials
- BLDEW Transportation Services
- Sector
- LOMA Industrials
- BLDEW Consumer Discretionary
- Exchange
- LOMA Nasdaq
- BLDEW Nasdaq
- Market Cap
- LOMA N/A
- BLDEW N/A
- IPO Year
- LOMA 2017
- BLDEW N/A
- Fundamental
- Price
- LOMA $12.35
- BLDEW $0.19
- Analyst Decision
- LOMA Strong Buy
- BLDEW
- Analyst Count
- LOMA 1
- BLDEW 0
- Target Price
- LOMA $14.00
- BLDEW N/A
- AVG Volume (30 Days)
- LOMA 389.8K
- BLDEW 51.0K
- Earning Date
- LOMA 06-10-2025
- BLDEW 03-13-2025
- Dividend Yield
- LOMA N/A
- BLDEW N/A
- EPS Growth
- LOMA 24.33
- BLDEW N/A
- EPS
- LOMA 0.77
- BLDEW N/A
- Revenue
- LOMA $636,700,779.00
- BLDEW $241,814,000.00
- Revenue This Year
- LOMA $46.71
- BLDEW N/A
- Revenue Next Year
- LOMA $27.41
- BLDEW N/A
- P/E Ratio
- LOMA $16.50
- BLDEW N/A
- Revenue Growth
- LOMA N/A
- BLDEW 12.04
- 52 Week Low
- LOMA $5.70
- BLDEW $0.30
- 52 Week High
- LOMA $14.17
- BLDEW $0.36
- Technical
- Relative Strength Index (RSI)
- LOMA 50.93
- BLDEW N/A
- Support Level
- LOMA $12.61
- BLDEW N/A
- Resistance Level
- LOMA $14.17
- BLDEW N/A
- Average True Range (ATR)
- LOMA 0.71
- BLDEW 0.00
- MACD
- LOMA -0.06
- BLDEW 0.00
- Stochastic Oscillator
- LOMA 26.02
- BLDEW 0.00
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.